India · Delayed Price · Currency is INR Dr. Agarwal's Health Care Statistics
Total Valuation
NSE:AGARWALEYE has a market cap or net worth of INR 165.08 billion. The enterprise value is 175.17 billion.
| Market Cap | 165.08B |
| Enterprise Value | 175.17B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:AGARWALEYE has 317.03 million shares outstanding. The number of shares has increased by 1.22% in one year.
| Current Share Class | 317.03M |
| Shares Outstanding | 317.03M |
| Shares Change (YoY) | +1.22% |
| Shares Change (QoQ) | +4.79% |
| Owned by Insiders (%) | 22.42% |
| Owned by Institutions (%) | 19.54% |
| Float | 121.26M |
Valuation Ratios
The trailing PE ratio is 98.13 and the forward PE ratio is 68.77. NSE:AGARWALEYE's PEG ratio is 1.51.
| PE Ratio | 98.13 |
| Forward PE | 68.77 |
| PS Ratio | 6.94 |
| PB Ratio | 7.32 |
| P/TBV Ratio | 15.85 |
| P/FCF Ratio | 364.50 |
| P/OCF Ratio | 30.45 |
| PEG Ratio | 1.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.80, with an EV/FCF ratio of 386.98.
| EV / Earnings | 102.29 |
| EV / Sales | 7.36 |
| EV / EBITDA | 31.80 |
| EV / EBIT | 51.06 |
| EV / FCF | 386.98 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.03 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.16 |
| Debt / FCF | 26.33 |
| Interest Coverage | 3.80 |
Financial Efficiency
Return on equity (ROE) is 9.66% and return on invested capital (ROIC) is 7.67%.
| Return on Equity (ROE) | 9.66% |
| Return on Assets (ROA) | 5.32% |
| Return on Invested Capital (ROIC) | 7.67% |
| Return on Capital Employed (ROCE) | 9.19% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.59 |
| Inventory Turnover | 14.29 |
Taxes
In the past 12 months, NSE:AGARWALEYE has paid 909.50 million in taxes.
| Income Tax | 909.50M |
| Effective Tax Rate | 30.68% |
Stock Price Statistics
The stock price has increased by +2.70% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.70% |
| 50-Day Moving Average | 495.22 |
| 200-Day Moving Average | 470.50 |
| Relative Strength Index (RSI) | 63.58 |
| Average Volume (20 Days) | 201,756 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AGARWALEYE had revenue of INR 23.58 billion and earned 1.70 billion in profits. Earnings per share was 5.31.
| Revenue | 23.58B |
| Gross Profit | 10.24B |
| Operating Income | 3.40B |
| Pretax Income | 2.96B |
| Net Income | 1.70B |
| EBITDA | 5.46B |
| EBIT | 3.40B |
| Earnings Per Share (EPS) | 5.31 |
Balance Sheet
The company has 1.71 billion in cash and 11.82 billion in debt, with a net cash position of -10.10 billion or -31.87 per share.
| Cash & Cash Equivalents | 1.71B |
| Total Debt | 11.82B |
| Net Cash | -10.10B |
| Net Cash Per Share | -31.87 |
| Equity (Book Value) | 22.36B |
| Book Value Per Share | 67.44 |
| Working Capital | 144.40M |
Cash Flow
In the last 12 months, operating cash flow was 5.37 billion and capital expenditures -4.92 billion, giving a free cash flow of 448.80 million.
| Operating Cash Flow | 5.37B |
| Capital Expenditures | -4.92B |
| Depreciation & Amortization | 2.06B |
| Net Borrowing | -1.29B |
| Free Cash Flow | 448.80M |
| FCF Per Share | 1.42 |
Margins
Gross margin is 43.43%, with operating and profit margins of 14.42% and 7.20%.
| Gross Margin | 43.43% |
| Operating Margin | 14.42% |
| Pretax Margin | 12.57% |
| Profit Margin | 7.20% |
| EBITDA Margin | 23.16% |
| EBIT Margin | 14.42% |
| FCF Margin | 1.90% |
Dividends & Yields
NSE:AGARWALEYE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.92% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.22% |
| Shareholder Yield | -1.22% |
| Earnings Yield | 1.02% |
| FCF Yield | 0.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:AGARWALEYE is 606.17, which is 16.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 606.17 |
| Price Target Difference | 16.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 22.08% |
| EPS Growth Forecast (3Y) | 42.42% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |